﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2024v5.2">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-10-28T14:58:12-05:00</ReturnTs>
    <TaxPeriodEndDt>2024-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>390974031</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>WEGNER CPAS LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>2921 LANDMARK PL STE 300</AddressLine1Txt>
        <CityNm>MADISON</CityNm>
        <StateAbbreviationCd>WI</StateAbbreviationCd>
        <ZIPCd>537134236</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>850342069</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>NORTH AMERICAN NEURO-OPHTHALMOLOGY</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>SOCIETY</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>NORT</BusinessNameControlTxt>
      <PhoneNum>9526462037</PhoneNum>
      <USAddress>
        <AddressLine1Txt>1935 COUNTY ROAD B2 W 165</AddressLine1Txt>
        <CityNm>ROSEVILLE</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>55113</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>MARK MOSTER MD</PersonNm>
      <PersonTitleTxt>TREASURER</PersonTitleTxt>
      <PhoneNum>9526462037</PhoneNum>
      <SignatureDt>2025-10-24</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>1</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>JENNY TARKOWSKI CPA</PreparerPersonNm>
      <PTIN>P00634290</PTIN>
      <PhoneNum>6082744020</PhoneNum>
      <PreparationDt>2025-10-24</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="6">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <PrincipalOfficerNm>TAMARA KINVILLE-OSSIAN</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>1935 COUNTY ROAD B2 W 165</AddressLine1Txt>
        <CityNm>ROSEVILLE</CityNm>
        <StateAbbreviationCd>MN</StateAbbreviationCd>
        <ZIPCd>55113</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>2233093</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.NANOSWEB.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1986</FormationYr>
      <LegalDomicileStateCd>NM</LegalDomicileStateCd>
      <ActivityOrMissionDesc>INCLUSIVE EXCELLENCE IN PATIENT CARE THROUGH EDUCATION, RESEARCH &amp; THE PRACTICE OF NEURO-OPHTHALMOLOGY.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>16</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>16</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>200</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>41382</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>44980</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>1586224</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>1746919</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>102065</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>212266</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>191233</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>228928</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>1920904</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>2233093</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>96869</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>97474</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>0</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>1368980</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>1514648</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>1465849</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>1612122</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>455055</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>620971</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>3665650</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>4351170</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>772921</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>776014</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>2892729</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>3575156</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>DEDICATED TO ACHIEVING INCLUSIVE EXCELLENCE IN THE CARE OF PATIENTS WITH NEURO-OPHTHALMIC DISEASES BY THE SUPPORT AND PROMOTION OF EQUITABLE EDUCATION, RESEARCH, AND THE PRACTICE OF NEURO-OPHTHALMOLOGY.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>1103766</ExpenseAmt>
      <GrantAmt>97474</GrantAmt>
      <RevenueAmt>1746919</RevenueAmt>
      <Desc>THE NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY (NANOS) IS THE ONLY ORGANIZATION DEDICATED TO THE ADVANCEMENT OF NEURO-OPHTHALMOLOGIC EDUCATION AND INFORMATION IN NORTH AMERICA. IN MARCH OF 2024, NANOS SPONSORED ITS 50TH ANNUAL MEETING, IN HONOLULU, HI. THE ON-DEMAND CONTENT OF OUR MEETING WAS AVAILABLE FOR ALMOST 6 MONTHS AFTER OUR IN-PERSON MEETING, TILL SEPTEMBER 30. THE EDUCATIONAL MEETING INCLUDES SYMPOSIA, WORKSHOPS, HANDS-ON TRAINING, PLATFORM AND POSTER PRESENTATIONS, AND DISCUSSION OF CASES AND BEST PRACTICES IN NEURO-OPHTHALMIC RESEARCH, BASIC SCIENCE, AND PATIENT CARE.NANOS USES MULTIPLE DATA SOURCES TO MEASURE THE IMPACT OF ITS EDUCATIONAL ACTIVITIES ON LEARNERS AND ON THE DISCIPLINE OF NEURO-OPHTHALMOLOGY. THESE MEASURES REFLECT PROFESSIONALS' NEED TO EXAMINE CURRENT PRACTICES, EVALUATE THE APPROPRIATENESS OF EDUCATIONAL ACTIVITIES IN ORDER TO IMPROVE THEIR LEVELS OF KNOWLEDGE OF NEURO-OPHTHALMOLOGY BASIC SCIENCE AND CLINICAL PRACTICE, COMPETENCE IN DIAGNOSING AND TREATING NEURO-OPHTHALMIC DISEASE, AND PERFORMANCE IN DIAGNOSING AND TREATING NEURO-OPHTHALMIC DISEASES.THE SOCIETY RECOGNIZES OUTSTANDING WORK AND PROVIDES BEST ABSTRACT AWARDS FOR PLATFORM AND POSTER PRESENTATIONS AT THE ANNUAL MEETING BY A RESIDENT, STUDENT OR FELLOW. THE SOCIETY GIVES A DISTINGUISHED SERVICE AWARD AT THE DISCRETION OF THE EXECUTIVE BOARD TO THOSE WHO HAVE PROVIDED A SUSTAINED AND SUBSTANTIAL SERVICE TO THE NORTH AMERICAN NEURO-OPHTHALMOLOGY SOCIETY.NANOS GIVES A YOUNG INVESTIGATOR AWARD. THIS AWARD WAS ESTABLISHED TO ENCOURAGE AND RECOGNIZE BASIC OR CLINICAL RESEARCH IN NEURO-OPHTHALMOLOGY BY A NANOS CANDIDATE OR ACTIVE MEMBER. THE ORIGINALITY, SCIENTIFIC MERIT AND NEURO-OPHTHALMIC INTEREST OF A DEVELOPMENT INVESTIGATOR'S TOTAL BODY OF WORK COMBINED WITH A REPRESENTATIVE NEW RESEARCH MANUSCRIPT WILL BE CONSIDERED AS CRITERIA TO DETERMINE THE AWARD RECIPIENT.NANOS RECOGNIZES THE NEED TO STIMULATE INVESTIGATOR-INITIATED RESEARCH PROGRAMS IN NEURO-OPHTHALMOLOGY. THE NANOS PILOT RESEARCH GRANT PROGRAM PROVIDES A ONE-YEAR, NON-RENEWABLE SOURCE OF FUNDING TO HELP PRINCIPAL INVESTIGATORS GENERATE PRELIMINARY DATA THAT WILL LEAD TO ADDITIONAL FUNDING FROM OTHER NATIONAL AGENCIES OR FOUNDATIONS. NANOS RECOGNIZES THE NEED TO STIMULATE LEADERSHIP DEVELOPMENT IN DIVERSE MEMBERS OF ITS COMMUNITY. THE DR. IVY DREIZIN LEADERSHIP DEVELOPMENT GRANT PROVIDES A ONETIME, NONRENEWABLE SOURCE OF FUNDING TO SUPPORT LEADERSHIP DEVELOPMENT FOR A NANOS MEMBER. PRIORITY IS GIVEN TO THOSE WHO HAVE BEEN ACTIVELY INVOLVED IN THE WOMEN IN NEUROOPHTHALMOLOGY COMMITTEE AND NANOS. NOMINEES AND ALTERNATES ARE SELECTED BY THE WOMEN IN NEUROOPHTHALMOLOGY STEERING COMMITTEE, SUBJECT TO APPROVAL BY THE NANOS BOARD OF DIRECTORS.THE SOCIETY HAS ITS OWN JOURNAL, THE JOURNAL OF NEUR0-OPHTHALMOLOGY.NANOS MEMBERS ARE PROVIDED WITH AN OPPORTUNITY TO JOIN AN E-MAIL SCIENTIFIC DISCUSSION GROUP.</Desc>
      <TotalProgramServiceExpensesAmt>1103766</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>0</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>1</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">0</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">1</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">0</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">0</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc1040500001">1</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc1040500001">1</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc1040500001">0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd>0</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>0</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd>0</DisregardedEntityInd>
      <RelatedEntityInd>0</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>0</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>14</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>16</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>16</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>1</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>1</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>1</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>1</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>1</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>1</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>0</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MN</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>GLOBAL MANAGEMENT PARTNERS LLC</PersonNm>
        <PhoneNum>9526462030</PhoneNum>
        <USAddress>
          <AddressLine1Txt>1935 COUNTY RD B2 W STE 165</AddressLine1Txt>
          <CityNm>ROSEVILLE</CityNm>
          <StateAbbreviationCd>MN</StateAbbreviationCd>
          <ZIPCd>55113</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <NoListedPersonsCompensatedInd>X</NoListedPersonsCompensatedInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>PETER QUIROS MD</PersonNm>
        <TitleTxt>PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HEATHER MOSS MD PHD</PersonNm>
        <TitleTxt>PRESIDENT-ELECT</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MELISSA KO MD</PersonNm>
        <TitleTxt>VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN CHEN MD PHD</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MARK MOSTER MD</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>3.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ANDREW LEE MD</PersonNm>
        <TitleTxt>SENIOR VP - NEURO-OPHTHALMIC ADVOCACY &amp; PRACTICE</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>NANCY NEWMAN MD</PersonNm>
        <TitleTxt>SENIOR VP - NEURO-OPHTHALMIC EDUCATION</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LARRY FROHMAN MD</PersonNm>
        <TitleTxt>EXECUTIVE VICE PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>8.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PREM SUBRAMANIAN MD PHD</PersonNm>
        <TitleTxt>IMMEDIATE PAST PRESIDENT/BOARD CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>10.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KEVIN LAI MD</PersonNm>
        <TitleTxt>MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>VICTORIA PELAK MD</PersonNm>
        <TitleTxt>MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>3.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LYNN GORDON MD PHD</PersonNm>
        <TitleTxt>MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JULIE FALARDEAU MD</PersonNm>
        <TitleTxt>MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>VALERIE BIOUSSE MD</PersonNm>
        <TitleTxt>MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>5.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ORE-OFE ADESINA MD</PersonNm>
        <TitleTxt>MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>COURTNEY FRANCIS MD</PersonNm>
        <TitleTxt>MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>4.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>TAMARA KINVILLE-OSSIAN</PersonNm>
        <TitleTxt>EXECUTIVE DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>0</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>0</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>0</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>0</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>0</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>GLOBAL MANAGEMENT PARTNERS LLC</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>1935 COUNTY RD B2 W STE 165</AddressLine1Txt>
            <CityNm>ROSEVILLE</CityNm>
            <StateAbbreviationCd>MN</StateAbbreviationCd>
            <ZIPCd>55113</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>MANAGEMENT SERVICES</ServicesDesc>
        <CompensationAmt>422371</CompensationAmt>
      </ContractorCompensationGrp>
      <ContractorCompensationGrp>
        <ContractorName>
          <BusinessName>
            <BusinessNameLine1Txt>M SQUARED ONSTAGE</BusinessNameLine1Txt>
          </BusinessName>
        </ContractorName>
        <ContractorAddress>
          <USAddress>
            <AddressLine1Txt>1780 CORPORATE DR 440</AddressLine1Txt>
            <CityNm>NORCROSS</CityNm>
            <StateAbbreviationCd>GA</StateAbbreviationCd>
            <ZIPCd>30093</ZIPCd>
          </USAddress>
        </ContractorAddress>
        <ServicesDesc>AUDIO VISUAL FOR ANNUAL MEETING</ServicesDesc>
        <CompensationAmt>155783</CompensationAmt>
      </ContractorCompensationGrp>
      <CntrctRcvdGreaterThan100KCnt>2</CntrctRcvdGreaterThan100KCnt>
      <AllOtherContributionsAmt>44980</AllOtherContributionsAmt>
      <TotalContributionsAmt>44980</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>ANNUAL MEETING</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>1285645</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1285645</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MEMBERSHIP DUES</Desc>
        <BusinessCd>813920</BusinessCd>
        <TotalRevenueColumnAmt>337106</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>337106</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>EDITORIAL SUPPORT</Desc>
        <BusinessCd>513120</BusinessCd>
        <TotalRevenueColumnAmt>81381</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>81381</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MARKETING COLLABORATION</Desc>
        <BusinessCd>541900</BusinessCd>
        <TotalRevenueColumnAmt>33000</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>33000</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>JOURNAL</Desc>
        <BusinessCd>513120</BusinessCd>
        <TotalRevenueColumnAmt>3100</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3100</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalOthProgramServiceRevGrp>
        <TotalRevenueColumnAmt>6687</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>6687</RelatedOrExemptFuncIncomeAmt>
      </TotalOthProgramServiceRevGrp>
      <TotalProgramServiceRevenueAmt>1746919</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>100850</TotalRevenueColumnAmt>
        <ExclusionAmt>100850</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>228928</TotalRevenueColumnAmt>
        <ExclusionAmt>228928</ExclusionAmt>
      </RoyaltiesRevenueGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>111416</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>0</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>111416</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>111416</TotalRevenueColumnAmt>
        <ExclusionAmt>111416</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>2233093</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1746919</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>441194</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>67018</TotalAmt>
        <ProgramServicesAmt>67018</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>5456</TotalAmt>
        <ProgramServicesAmt>5456</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <ForeignGrantsGrp>
        <TotalAmt>25000</TotalAmt>
        <ProgramServicesAmt>25000</ProgramServicesAmt>
      </ForeignGrantsGrp>
      <FeesForServicesManagementGrp>
        <TotalAmt>422371</TotalAmt>
        <ManagementAndGeneralAmt>422371</ManagementAndGeneralAmt>
      </FeesForServicesManagementGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>2436</TotalAmt>
        <ManagementAndGeneralAmt>2436</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>2400</TotalAmt>
        <ManagementAndGeneralAmt>2400</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <AdvertisingGrp>
        <TotalAmt>1500</TotalAmt>
        <ManagementAndGeneralAmt>1500</ManagementAndGeneralAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>37794</TotalAmt>
        <ProgramServicesAmt>1000</ProgramServicesAmt>
        <ManagementAndGeneralAmt>36794</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>22039</TotalAmt>
        <ProgramServicesAmt>1400</ProgramServicesAmt>
        <ManagementAndGeneralAmt>20639</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>31850</TotalAmt>
        <ProgramServicesAmt>31850</ProgramServicesAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>762954</TotalAmt>
        <ProgramServicesAmt>745669</ProgramServicesAmt>
        <ManagementAndGeneralAmt>17285</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <InsuranceGrp>
        <TotalAmt>8646</TotalAmt>
        <ProgramServicesAmt>3760</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4886</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>JOURNAL</Desc>
        <TotalAmt>222613</TotalAmt>
        <ProgramServicesAmt>222613</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>45</TotalAmt>
        <ManagementAndGeneralAmt>45</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>1612122</TotalAmt>
        <ProgramServicesAmt>1103766</ProgramServicesAmt>
        <ManagementAndGeneralAmt>508356</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>213794</BOYAmt>
        <EOYAmt>567700</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>623394</BOYAmt>
        <EOYAmt>319495</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>68477</BOYAmt>
        <EOYAmt>101383</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>208434</BOYAmt>
        <EOYAmt>96053</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>2244225</BOYAmt>
        <EOYAmt>2739150</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>307326</BOYAmt>
        <EOYAmt>527389</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <TotalAssetsGrp>
        <BOYAmt>3665650</BOYAmt>
        <EOYAmt>4351170</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>31585</BOYAmt>
        <EOYAmt>14653</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>741336</BOYAmt>
        <EOYAmt>761361</EOYAmt>
      </DeferredRevenueGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>772921</BOYAmt>
        <EOYAmt>776014</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>2875965</BOYAmt>
        <EOYAmt>3558104</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>16764</BOYAmt>
        <EOYAmt>17052</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>2892729</BOYAmt>
        <EOYAmt>3575156</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>3665650</BOYAmt>
        <EOYAmt>4351170</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>620971</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>61456</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>0</FSAuditedInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>35260</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>61116</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>32937</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>41382</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>44980</CurrentTaxYearAmt>
        <TotalAmt>215675</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>1010580</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>918159</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1381806</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1586224</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1746919</CurrentTaxYearAmt>
        <TotalAmt>6643688</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>1045840</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>979275</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1414743</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1627606</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1791899</CurrentTaxYearAmt>
        <TotalAmt>6859363</TotalAmt>
      </Total509Grp>
      <AmountsRcvdDsqlfyPersonGrp>
        <TotalAmt>0</TotalAmt>
      </AmountsRcvdDsqlfyPersonGrp>
      <SubstantialContributorsAmtGrp>
        <CurrentTaxYearMinus1YearAmt>234058</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>217148</CurrentTaxYearAmt>
        <TotalAmt>451206</TotalAmt>
      </SubstantialContributorsAmtGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <CurrentTaxYearMinus1YearAmt>234058</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>217148</CurrentTaxYearAmt>
        <TotalAmt>451206</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>6408157</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>54696</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>74550</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>50543</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>263061</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>329778</CurrentTaxYearAmt>
        <TotalAmt>772628</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>54696</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>74550</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>50543</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>263061</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>329778</CurrentTaxYearAmt>
        <TotalAmt>772628</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <OtherIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>15809</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>25186</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>17942</CurrentTaxYearMinus2YearsAmt>
        <TotalAmt>58937</TotalAmt>
      </OtherIncome509Grp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>1116345</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1079011</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1483228</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1890667</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2121677</CurrentTaxYearAmt>
        <TotalAmt>7690928</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.83320</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.88100</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.10050</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.07300</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME:</FormAndLineReferenceDesc>
        <ExplanationTxt>MISCELLANEOUS - 2020 AMOUNT: $ 15,809. 2021 AMOUNT: $ 25,186. 2022 AMOUNT: $ 17,942.</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>16764</BeginningYearBalanceAmt>
        <ContributionsAmt>1000</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>288</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>1000</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>17052</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>18458</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>306</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>2000</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>16764</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>19374</BeginningYearBalanceAmt>
        <GrantsOrScholarshipsAmt>916</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>18458</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>19000</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>1314</InvestmentEarningsOrLossesAmt>
        <GrantsOrScholarshipsAmt>940</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>19374</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>20000</BeginningYearBalanceAmt>
        <GrantsOrScholarshipsAmt>1000</GrantsOrScholarshipsAmt>
        <EndYearBalanceAmt>19000</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.00000</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.00000</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>1.00000</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <TotalBookValueLandBuildingsAmt>0</TotalBookValueLandBuildingsAmt>
      <OtherSecuritiesGrp>
        <Desc>MONEY MARKET FUNDS</Desc>
        <BookValueAmt>527389</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <TotalBookValueSecuritiesAmt>527389</TotalBookValueSecuritiesAmt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ENDOWMENT IS TO BE USED FOR THE DR. JAMES A. SHARPE RESEARCH AWARD FOR THE BEST FELLOW RESEARCH PAPER.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc1040500001">
      <GrantRecordsMaintainedInd>0</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>MIDDLE EAST AND NORTH AFRICA</RegionTxt>
        <OfficesCnt>0</OfficesCnt>
        <EmployeeCnt>0</EmployeeCnt>
        <TypeOfActivitiesConductedTxt>GRANTS TO OTHERS</TypeOfActivitiesConductedTxt>
        <RegionTotalExpendituresAmt>25000</RegionTotalExpendituresAmt>
      </AccountActivitiesOutsideUSGrp>
      <SubtotalOfficesCnt>0</SubtotalOfficesCnt>
      <SubtotalEmployeesCnt>0</SubtotalEmployeesCnt>
      <ContinuationTotalOfficeCnt>0</ContinuationTotalOfficeCnt>
      <ContinuationTotalEmployeeCnt>0</ContinuationTotalEmployeeCnt>
      <TotalOfficeCnt>0</TotalOfficeCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <SubtotalSpentAmt>25000</SubtotalSpentAmt>
      <ContinuationSpentAmt>0</ContinuationSpentAmt>
      <TotalSpentAmt>25000</TotalSpentAmt>
      <GrantsToOrgOutsideUSGrp>
        <RegionTxt>MIDDLE EAST AND NORTH AFRICA</RegionTxt>
        <PurposeOfGrantTxt>TO STIMULATE INVESTIGATOR-INITIATED RESEARCH</PurposeOfGrantTxt>
        <CashGrantAmt>25000</CashGrantAmt>
        <NonCashAssistanceAmt>0</NonCashAssistanceAmt>
      </GrantsToOrgOutsideUSGrp>
      <Total501c3OrgCnt>0</Total501c3OrgCnt>
      <TotalOtherOrgCnt>1</TotalOtherOrgCnt>
      <TransferToForeignCorpInd>0</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>0</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>0</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>0</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>0</ForeignPartnershipInd>
      <BoycottCountriesInd>0</BoycottCountriesInd>
    </IRS990ScheduleF>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>CHILDREN'S HOSPITAL LOS ANGELES UNIVERSITY OF SOUTHERN CALIFORNIA</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4650 SUNSET BLVD</AddressLine1Txt>
          <CityNm>LOS ANGELES</CityNm>
          <StateAbbreviationCd>CA</StateAbbreviationCd>
          <ZIPCd>90027</ZIPCd>
        </USAddress>
        <RecipientEIN>951690977</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>0</CashGrantAmt>
        <NonCashAssistanceAmt>12500</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>TO STIMULATE INVESTIGATOR-INITIATED RESEARCH IN NEURO-OPHTHALMOLOGY</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>ECCLES HEALTH SCIENCES LIBRARY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>10 N 1900 E</AddressLine1Txt>
          <CityNm>SALT LAKE CITY</CityNm>
          <StateAbbreviationCd>UT</StateAbbreviationCd>
          <ZIPCd>84112</ZIPCd>
        </USAddress>
        <RecipientEIN>876000525</RecipientEIN>
        <IRCSectionDesc>501(C)(3)</IRCSectionDesc>
        <CashGrantAmt>0</CashGrantAmt>
        <NonCashAssistanceAmt>49518</NonCashAssistanceAmt>
        <PurposeOfGrantTxt>TO ADVANCE AND PROMOTE EQUITABLE EDUCATION AND RESEARCH IN NEURO-OPHTHALMOLOGY</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <TotalOtherOrgCnt>0</TotalOtherOrgCnt>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>SPECIAL PROJECTS</GrantTypeTxt>
        <RecipientCnt>2</RecipientCnt>
        <CashGrantAmt>5456</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE NOVEL TEAM PROVIDES THE NANOS BOARD WITH AN ANNUAL REPORT ON HOW THE FUNDS ARE USED THROUGHOUT THE YEAR AND MAKES A PRESENTATION DURING THE NANOS BOARD MEETING IN FEBRUARY/MARCH. THE NANOS RESEARCH COMMITTEE ASKS FOR THE MID-YEAR PROGRESS REPORT FROM PILOT GRANT RECIPIENTS PRIOR TO ISSUING THE SECOND GRANT PAYMENT; UPON COMPLETION OF THE PILOT RESEARCH PROJECT, THE INVESTIGATORS ARE ASKED TO COMPLETE A SURVEY REGARDING THE OUTCOMES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>DR. VALERIE BIOUSSE AND DR. NANCY NEWMAN HAVE A FAMILY RELATIONSHIP.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>THE SOCIETY HAS CONTRACTED WITH GLOBAL MANAGEMENT PARTNERS, LLC TO PROVIDE OFFICE SPACE AND ADMINISTRATIVE SERVICES TO THE ORGANIZATION. TAMARA KINVILLE-OSSIAN, THE ORGANIZATION'S EXECUTIVE DIRECTOR, IS EMPLOYED BY GLOBAL MANAGEMENT PARTNERS, LLC. DURING THE TAX YEAR ENDED DECEMBER 31, 2024, THE SOCIETY PAID $422,371 TO GLOBAL MANAGEMENT PARTNERS, LLC FOR OFFICE SPACE AND ADMINISTRATION FEES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>MEMBERSHIP IN NANOS CONSISTS OF ELEVEN CLASSES: FELLOW, INTERNATIONAL FELLOW, ACTIVE MEMBER, INTERNATIONAL ACTIVE MEMBER, CANDIDATE, INTERNATIONAL CANDIDATE, ASSOCIATE MEMBER, HONORARY MEMBER, SENIOR FELLOW MEMBER, SENIOR MEMBER, AND STUDENT MEMBER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7A</FormAndLineReferenceDesc>
        <ExplanationTxt>ONLY MEMBERS IN THE FOLLOWING CLASSES OF MEMBERSHIP ARE ENTITLED TO VOTE ON ANY MATTER IN PERSON OR BY PROXY DURING ANY ANNUAL OR SPECIAL BUSINESS MEETING OF THE SOCIETY OR BY ELECTRONIC VOTING: FELLOWS, INTERNATIONAL FELLOWS, ACTIVE MEMBERS, INTERNATIONAL ACTIVE MEMBERS, SENIOR FELLOW MEMBERS, AND THOSE SENIOR MEMBERS WHO HAD VOTING PRIVILEGES IN THEIR MOST RECENT PREVIOUS CATEGORY OF MEMBERSHIP.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE BYLAWS MAY BE AMENDED, ALTERED OR REPEALED BY THE VOTE OF AT LEAST TWO-THIRDS OF THE ELIGIBLE VOTERS, EITHER BY PHYSICAL PRESENCE AT A MEETING OR BY ELECTRONIC BALLOT OF ALL OF THE ELIGIBLE VOTERS, PROVIDED THAT ANY PROPOSED AMENDMENT 1) HAS BEEN SUBMITTED IN WRITING TO THE EXECUTIVE BOARD AND 2) NOTICE THEREOF HAS BEEN PROVIDED TO EACH FELLOW AND OTHER VOTING MEMBER AT LEAST ONE MONTH PRIOR TO THE DATE ON WHICH IT WILL BE VOTED UPON.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FORM 990 WILL BE REVIEWED BY THE ORGANIZATION'S ACCOUNTING TEAM, EXECUTIVE DIRECTOR, AND BOARD BEFORE FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>PURSUANT TO THE ORGANIZATION'S WRITTEN CONFLICT OF INTEREST DISCLOSURE POLICY, THE NANOS EXECUTIVE COMMITTEE WILL OBTAIN AND CONFIDENTIALLY REVIEW INFORMATION FROM LEADERSHIP AND STAFF ON AN ANNUAL DISCLOSURE REVIEW FORM, AND ALERT THE BOARD OF ANY SERIOUS CONFLICTS. COMPLETION OF THE CONFLICT OF INTEREST DISCLOSURE FORM WILL SATISFY THE DISCLOSURE REQUIREMENTS OF THE POLICY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>INSPECTION IS AVAILABLE BY APPOINTMENT WITH THE GMP PARTNER.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>